Yesterday Creso issued the following press release highlighting their key points
Essentially the IP land grab in psychedelics is continuing apace and everybody wants a piece of the action.
Creso are no exception.
Halucenex Life Sciences Inc. enters into advisory agreement with biotechnology company Growing Together Research Inc. Halucenex to expand R&D into other compounds such as LSD, MDMA and Ketamine Due Diligence on the Halucenex acquisition continues positively
Highlights
• Growing Together Research Inc. is a US-based biotechnology company focused on applying cutting-edge computational genomics and bioengineering to plant medicine
• Advisory agreement will allow Halucenex to gain a better understanding of components of psychedelic mushrooms and use for specific conditions
• Initial data from sequencing expected to assist Halucenex with treatment development initiatives and generating higher yield from extraction and cultivation • Agreement expected to lay foundation for bolstering intellectual property portfolio
• Strategic decision to further expand research initiatives and include other psychedelic compounds such as LSD, MDMA and Ketamine
Full Press Release
02362448
